Tech Company Financing Transactions

SciFluor Life Sciences Funding Round

On 6/30/2011, SciFluor Life Sciences secured $5 million in financing from Allied Minds.

Transaction Overview

Announced On
6/30/2011
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 Technology Sq. 201
Cambridge, MA 02139
USA
Email Address
Overview
The company's late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor's technology enables end-stage or any-stage fluorination of a wide variety of organic compounds. Our technology and our library of fluorinated analogs are protected by an extensive intellectual property portfolio.
Profile
SciFluor Life Sciences LinkedIn Company Profile
Social Media
SciFluor Life Sciences Company Twitter Account
Company News
SciFluor Life Sciences News
Facebook
SciFluor Life Sciences on Facebook
YouTube
SciFluor Life Sciences on YouTube

Management Team

Title
Name
Email & Social
Chairman
William Koster
  William Koster LinkedIn Profile  William Koster Twitter Account  William Koster News  William Koster on Facebook
Chief Executive Officer
Omar Amirana
  Omar Amirana LinkedIn Profile  Omar Amirana Twitter Account  Omar Amirana News  Omar Amirana on Facebook
Founder
Takeru Furuya
  Takeru Furuya LinkedIn Profile  Takeru Furuya Twitter Account  Takeru Furuya News  Takeru Furuya on Facebook
Founder
Tobias Ritter
  Tobias Ritter LinkedIn Profile  Tobias Ritter Twitter Account  Tobias Ritter News  Tobias Ritter on Facebook
Vice President
Scott Edwards
  Scott Edwards LinkedIn Profile  Scott Edwards Twitter Account  Scott Edwards News  Scott Edwards on Facebook
VP - R & D
Benjamin Askew
  Benjamin Askew LinkedIn Profile  Benjamin Askew Twitter Account  Benjamin Askew News  Benjamin Askew on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2011: Tangent Energy Solutions venture capital transaction
Next: 6/30/2011: Ascletis venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary